“Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s717. Accessed January 14, 2026. https://skin.dermsquared.com/skin/article/view/3770.